Symbol
| PRL
| contributors: mct/pgu - updated : 03-01-2023
|
HGNC name
| prolactin
|
HGNC id
| 9445
|
Other morbid association(s)
|
Type | Gene Modification | Chromosome rearrangement | Protein expression | Protein Function
|
---|
constitutional
|  
|  
| --over
|  
|
has been described in relation to the pathogenesis and activity of several autoimmune disorders | constitutional
|  
|  
| --over
|  
|
in decreased bone mineral density as well as in increased risk of fractures | |
Susceptibility
|
to breast cancer to increased adiposity in males |
Variant & Polymorphism
SNP
| SNP rs4712652 near the PRL gene seems to affect body fat and adiposity in a sex-specific fashion |
|
|
|
|
Candidate gene
Marker
Therapy target
|
System | Type | Disorder | Pubmed |
cardiovascular | cardiomyopathy | | |
inhibition of prolactin release by bromocriptine may represent a novel therapeutic strategy for postpartum cardiomyopathy | neurology | neurodegenerative | Parkinson/dementia Parkinsonism | |
promising molecule for the treatment of PD | neurology | neurodegenerative | alzheimer | |
promising molecule for the treatment of AD |
| | | |
| Prl is required for maintaining retinal functionality in both female and male mice during aging and has potential therapeutic value against age-related retinal disorders |